TrialJAMA psychiatry2026

Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical Trial.

Marie R Sass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.